310 related articles for article (PubMed ID: 11564866)
1. Use of chromatin immunoprecipitation to clone novel E2F target promoters.
Weinmann AS; Bartley SM; Zhang T; Zhang MQ; Farnham PJ
Mol Cell Biol; 2001 Oct; 21(20):6820-32. PubMed ID: 11564866
[TBL] [Abstract][Full Text] [Related]
2. The identification of E2F1-specific target genes.
Wells J; Graveel CR; Bartley SM; Madore SJ; Farnham PJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3890-5. PubMed ID: 11904439
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
4. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
Hsiao KM; McMahon SL; Farnham PJ
Genes Dev; 1994 Jul; 8(13):1526-37. PubMed ID: 7958837
[TBL] [Abstract][Full Text] [Related]
5. Heregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcription.
Zhang Y; Hamburger AW
J Biol Chem; 2004 Jun; 279(25):26126-33. PubMed ID: 15073182
[TBL] [Abstract][Full Text] [Related]
6. E2F1-mediated transcriptional inhibition of the plasminogen activator inhibitor type 1 gene.
Koziczak M; Müller H; Helin K; Nagamine Y
Eur J Biochem; 2001 Sep; 268(18):4969-78. PubMed ID: 11559366
[TBL] [Abstract][Full Text] [Related]
7. S Phase-specific transcription of the mouse ribonucleotide reductase R2 gene requires both a proximal repressive E2F-binding site and an upstream promoter activating region.
Chabes AL; Björklund S; Thelander L
J Biol Chem; 2004 Mar; 279(11):10796-807. PubMed ID: 14688249
[TBL] [Abstract][Full Text] [Related]
8. E2F in vivo binding specificity: comparison of consensus versus nonconsensus binding sites.
Rabinovich A; Jin VX; Rabinovich R; Xu X; Farnham PJ
Genome Res; 2008 Nov; 18(11):1763-77. PubMed ID: 18836037
[TBL] [Abstract][Full Text] [Related]
9. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
10. E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas.
Kramps C; Strieder V; Sapetschnig A; Suske G; Lutz W
J Biol Chem; 2004 Feb; 279(7):5110-7. PubMed ID: 14645238
[TBL] [Abstract][Full Text] [Related]
11. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
12. Apaf-1 is a mediator of E2F-1-induced apoptosis.
Furukawa Y; Nishimura N; Furukawa Y; Satoh M; Endo H; Iwase S; Yamada H; Matsuda M; Kano Y; Nakamura M
J Biol Chem; 2002 Oct; 277(42):39760-8. PubMed ID: 12149244
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
[TBL] [Abstract][Full Text] [Related]
14. Cloning, chromosomal location, and characterization of mouse E2F1.
Li Y; Slansky JE; Myers DJ; Drinkwater NR; Kaelin WG; Farnham PJ
Mol Cell Biol; 1994 Mar; 14(3):1861-9. PubMed ID: 8114719
[TBL] [Abstract][Full Text] [Related]
15. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
16. Aberrant regulation of survivin by the RB/E2F family of proteins.
Jiang Y; Saavedra HI; Holloway MP; Leone G; Altura RA
J Biol Chem; 2004 Sep; 279(39):40511-20. PubMed ID: 15271987
[TBL] [Abstract][Full Text] [Related]
17. The use of transient chromatin immunoprecipitation assays to test models for E2F1-specific transcriptional activation.
Lavrrar JL; Farnham PJ
J Biol Chem; 2004 Oct; 279(44):46343-9. PubMed ID: 15328355
[TBL] [Abstract][Full Text] [Related]
18. The human p73 promoter: characterization and identification of functional E2F binding sites.
Seelan RS; Irwin M; van der Stoop P; Qian C; Kaelin WG; Liu W
Neoplasia; 2002; 4(3):195-203. PubMed ID: 11988839
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the human cyclin-dependent kinase inhibitor p18INK4c by the transcription factors E2F1 and Sp1.
Blais A; Monté D; Pouliot F; Labrie C
J Biol Chem; 2002 Aug; 277(35):31679-93. PubMed ID: 12077144
[TBL] [Abstract][Full Text] [Related]
20. The SANT domain of human MI-ER1 interacts with Sp1 to interfere with GC box recognition and repress transcription from its own promoter.
Ding Z; Gillespie LL; Mercer FC; Paterno GD
J Biol Chem; 2004 Jul; 279(27):28009-16. PubMed ID: 15117948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
